RxDoctor Payments DataLook up a doctor →

Samir Arora

Powell, OHNPI 1134133598

Payments from drug & device makers

$17,486,531in general payments, 2019–2025

Across 2,308 payments — averaging $7576.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$10.7M
  • Eli Lilly$1.8M
  • AbbVie$1.1M
  • AstraZeneca$1.1M
  • Emergent Biosolutions Inc.$887K
  • Biontech SE$437K
  • plus $1.5M from 19 others
$15,299in research payments, 2019–2025

Across 34 payments — averaging $449.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$12K
  • Sanofi US Services Inc.$3K
  • Glenmark Pharmaceuticals Inc., USA$165
  • GSK$45

What the payments were for

  • Travel & lodging$2,18956%
  • Food & beverage$1,67143%
  • Gifts$201%

General payments by program year

19
20
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →